Uwe Gottschalk is Operating Partner at Keensight Capital - Former CSO of Lonza

CSO of Bionova Scientific

Director Global Cell & Gene Therapies Portfolio Management at Novartis

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

President, Science and Technology at Cabaletta Bio

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

Jens H. Vogel
President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals